Quarterly UpdatesMay 6, 2026, 08:13 AM
High Tide's Remexian Pharma Reports Record 7.6 Tonnes Medical Cannabis Distribution
AI Summary
High Tide Inc. announced that its 51%-owned German subsidiary, Remexian Pharma GmbH, distributed a record 7.6 tonnes of medical cannabis in Germany during the second fiscal quarter ended April 30, 2026. This represents a 21% sequential increase and a 49% year-over-year growth, demonstrating the company's scaling in the European medical cannabis market. CEO Raj Grover emphasized leveraging High Tide's procurement capabilities for further expansion across Europe.
Key Highlights
- Remexian Pharma distributed a record 7.6 tonnes of medical cannabis in Q2 2026.
- Quarterly distribution volume increased 21% sequentially.
- Distribution volume grew 49% year-over-year.
- Germany imported 201.1 tonnes of medical cannabis in 2025, doubling from 72.9 tonnes in 2024.
- Almost half of Germany's 2025 medical cannabis imports (over 93 tonnes) came from Canada.